
Dr. Alissa Greenbaum and Dr. Kimberly Kopecky will talk openly about setting realistic expectations before surgery, what we know about decision regret, including the latest research, and the important, often challenging role caregivers play.
Dr. Alissa Greenbaum and Dr. Kimberly Kopecky will talk openly about setting realistic expectations before surgery, what we know about decision regret, including the latest research, and the important, often challenging role caregivers play.
Education in Fundamentals
Moderator: Dr. Edward Levine from Atrium Health Levine Cancer
State of the Science & Ongoing Developments
Moderator: Dr. Laura Lambert, University of Utah Huntsman Cancer Institute
Moderator: Dr. Edward Levine from Atrium Health Levine Cancer
Moderator: Dr. Laura Lambert, University of Utah Huntsman Cancer Institute
Moderator: Dr. Kiran Turaga, Yale School of Medicine
Dr. Elizabeth Godfrey’s project DECISIVE aims to address this problem by comprehensively understanding the decision-making experiences of individuals and their caregivers considering cytoreductive surgery and using that knowledge to develop a decision aid that would support and improve the decision-making process.
This webinar, featuring Travera, allows patients to participate in testing a potentially groundbreaking technology.
Dr. Michael Foote, a Medical Oncologist at Memorial Sloan Kettering Cancer Center, talked to us about the recent immunotherapy revolution that has created considerable excitement for treatments that boost the immune system to fight cancer and avoid chemotherapy-related side effects.
Moderated by Dr. Edward Levine, Atrium Health Levine Cancer
Topics:
Appendix Cancer: An Overview, Pathology: Navigating the Complex Maze, Chemotherapy for Appendix Cancer Current Landscape, Mock Tumor Board: Putting It All Together, Ask the Experts
Moderated by Dr. Laura Lambert, Huntsman Cancer Institute
Topics: Papers of the Year for Appendiceal Cancer, Highlights from PSOGI 2023, Snapshots of Select Clinical Trials for Appendix Cancer, Genetics and Genomic Sequencing, Organoids to Personalize Chemotherapy